Bio Protocol vs STBL — how do they compare? Bio Protocol trades at Rp442.5 (market cap Rp1,01T, Rp168,09M 24h volume), while STBL trades at Rp404.9 (market cap Rp283,55M, Rp20,6M 24h volume). The key difference: Bio Protocol is far larger — about 3562× STBL's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 700M / 10B STBL (8%) for STBL. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and STBL for 7 Days on average.
| BIO | STBL | |
|---|---|---|
Market Cap | Rp1,01T | Rp283,55M |
Volume (24h) | Rp168,09M | Rp20,6M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 700M / 10B STBL (8%) |
Typical Hold Time | 18 Days | 7 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →STBL is a decentralized stablecoin protocol that separates real-world asset collateral into a spendable stablecoin (USST) and a yield-bearing NFT (YLD), governed by the STBL token. Its three-token architecture distinguishes liquidity, yield, and governance functions. Backed by tokenized Treasuries and money market funds, the protocol emphasizes transparency and community-driven decision-making.
Read more on STBL →